DK105888D0 - Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel - Google Patents

Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel

Info

Publication number
DK105888D0
DK105888D0 DK105888A DK105888A DK105888D0 DK 105888 D0 DK105888 D0 DK 105888D0 DK 105888 A DK105888 A DK 105888A DK 105888 A DK105888 A DK 105888A DK 105888 D0 DK105888 D0 DK 105888D0
Authority
DK
Denmark
Prior art keywords
medicine
procedure
manufacture
active material
biologically active
Prior art date
Application number
DK105888A
Other languages
English (en)
Other versions
DK105888A (da
Inventor
Sven Engstroem
Kaare Viktor Larsson
Bjoern Lindman
Original Assignee
Drilletten Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drilletten Ab filed Critical Drilletten Ab
Publication of DK105888D0 publication Critical patent/DK105888D0/da
Publication of DK105888A publication Critical patent/DK105888A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK105888A 1986-07-01 1988-02-29 Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel DK105888A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
PCT/SE1987/000279 WO1988000059A1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase

Publications (2)

Publication Number Publication Date
DK105888D0 true DK105888D0 (da) 1988-02-29
DK105888A DK105888A (da) 1988-02-29

Family

ID=20364989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK105888A DK105888A (da) 1986-07-01 1988-02-29 Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel

Country Status (8)

Country Link
EP (1) EP0314689B1 (da)
JP (1) JPH0759523B2 (da)
CA (1) CA1296631C (da)
DE (1) DE3778024D1 (da)
DK (1) DK105888A (da)
FI (1) FI97687C (da)
SE (1) SE457693B (da)
WO (1) WO1988000059A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
EP0429419B1 (en) * 1989-10-20 1996-02-14 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
CA2231404C (en) 1994-11-03 2009-02-17 Arzneimittelwerk Dresden Gmbh Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
NZ336900A (en) 1997-01-30 2001-06-29 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions comprising cyclosporin A and being substantially free of any oil
CN1138591C (zh) * 1997-09-09 2004-02-18 莱奥特罗皮克治疗公司 包覆颗粒以及其制备和使用方法
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
CN114145290A (zh) * 2021-06-02 2022-03-08 贵州省烟草科学研究院 高效长效昆虫性诱芯及其制作方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
FI886055A (fi) 1988-12-30
FI97687C (fi) 1997-02-10
CA1296631C (en) 1992-03-03
JPH01503140A (ja) 1989-10-26
FI97687B (fi) 1996-10-31
SE457693B (sv) 1989-01-23
DK105888A (da) 1988-02-29
EP0314689B1 (en) 1992-04-01
WO1988000059A1 (en) 1988-01-14
EP0314689A1 (en) 1989-05-10
JPH0759523B2 (ja) 1995-06-28
SE8602931D0 (sv) 1986-07-01
SE8602931L (sv) 1988-01-02
DE3778024D1 (da) 1992-05-07

Similar Documents

Publication Publication Date Title
DK105888A (da) Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK495585D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
NO871774D0 (no) Medikament-system med kontrollert frisettelse av det aktive middel.
DK137488D0 (da) Praeparater med kontrolleret frigivelse af aktive stoffer
DK236285D0 (da) Anordning til langsom frigivelse af et medikament i en droevtyggers mave
DK343388D0 (da) 2,2-dimethylchroman-3-ol-derivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne samt disse anvendelse til fremstilling af farmaceutiske midler
DK610988A (da) Polypeptider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater der indeholder dem samt anvendelse deraf til fremstilling af et laegemiddel
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK364987D0 (da) Laegemiddelholdige fibre med kontrolleret frigoerelse og fremgangsmaade til fremstilling heraf
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK106685A (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
DK164149C (da) Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
DK95489A (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
DK430188A (da) Antithrombolisk materiale til medicinsk anvendelse samt fremgangsmaade til fremstilling deraf
DK632388A (da) Pharmaceutisk middel til behandling af hyperlipidaemi hol pattedyr
DK561787D0 (da) Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
SG103391G (en) Pharmaceutical formulations with controlled release of the active substance
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK39584A (da) Anvendelse af nafazatrom til forebyggelse og behandling af diverse sygdomme, laegemidler indeholdende nafazatrom samt fremgangsmaader til disses fremstilling
DK423385A (da) Laegemiddel samt anvendelse af alfa-interferoner til fremstilling af et middel til behandling af diarre
DK50288A (da) Anvendelse af et benzo-c-phenanthridinalkaloid til fremstilling af et farmaceutisk middel

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment